Defensin Beta 125: Potential Drug Target Or Biomarker (G245938)

Target Name: DEFB125

NCBI ID: G245938

DEFB125

Defensin Beta 125: Potential Drug Target Or Biomarker

Defensin beta 125 (DEFB125) is a protein that is expressed in various tissues throughout the body, including the skin, lungs, heart, kidneys, and intestines. It is a member of the defensin family of proteins, which are involved in the immune response. While defensin beta 125 is not a well-known protein by itself, it is potential drug target or biomarker in several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

Potential Drug Target

One of the most promising aspects of defensin beta 125 is its potential as a drug target. Defensin beta 125 has been shown to play a role in several immune-related processes, including inflammation, infection, and cancer. It is involved in the regulation of T cell responses, and it has been shown to contribute to the development of cancer in several models.

For example, studies have shown that defensin beta 125 is involved in the regulation of T cell responses to viruses, including HIV and herpes simplex virus. In addition, defensin beta 125 has been shown to contribute to the development of skin cancer, and it has been shown to play a role in the regulation of inflammation and autoimmune disorders.

Potential Biomarker

In addition to its potential as a drug target, defensin beta 125 is also a potential biomarker for several diseases. Its expression has been shown in a variety of tissues and has been associated with several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

For example, defensin beta 125 has been shown to be expressed in several types of cancer, including breast, lung, and ovarian cancer. It has also been shown to be involved in the development of neurodegenerative diseases, including Alzheimer's and Parkinson's diseases. In addition, defensin beta 125 has been shown to be involved in the regulation of autoimmune disorders, including rheumatoid arthritis and multiple sclerosis.

Conclusion

Defensin beta 125 is a protein that is expressed in various tissues throughout the body and is involved in several immune-related processes. While it is not a well-known protein by itself, its potential as a drug target or biomarker for several diseases makes it a promising target for future research. Further studies are needed to fully understand the role of defensin beta 125 in disease and to develop effective treatments.

Protein Name: Defensin Beta 125

Functions: Has antibacterial activity

The "DEFB125 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DEFB125 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets